[1]
N. K., S. S., I. L., T. A., R. P., and S. P. T., “TARGETING NUCLEAR FACTOR KAPPA B WITH CHELATED ZINC COMPOUNDS TOWARDS ANTICANCER DRUG DESIGN”, Int J App Pharm, vol. 13, no. 4, pp. 123–127, Jul. 2021.